Regulatory sites in the melatonin system of mammals
- PMID: 1701580
- DOI: 10.1016/0166-2236(90)90100-o
Regulatory sites in the melatonin system of mammals
Abstract
The hormone melatonin was first identified about 30 years ago as a secretory product of the pineal gland. In mammals, the daily rhythm of pineal melatonin synthesis is controlled by neural inputs. The CNS is thought to be a primary target organ involved in mediating the influence of melatonin on a variety of physiological and behavioral processes, including biological rhythms, neuroendocrine function, activity levels and sleep. It now appears that melatonin is also produced in the retina and affects various aspects of retinal physiology. The purpose of this article is to provide a brief overview of potential regulatory sites involved in the production and action of melatonin. In particular, this review focuses on the rapid advances being made in the characterization and localization of melatonin receptors in the CNS, retina and pituitary and on recent findings pertaining to the regulation of melatonin synthesis in the mammalian pineal gland and retina.
Similar articles
-
Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology.Rev Reprod. 1998 Jan;3(1):13-22. doi: 10.1530/ror.0.0030013. Rev Reprod. 1998. PMID: 9509985
-
Melatonin receptors in the central nervous system.Adv Exp Med Biol. 1991;294:255-65. doi: 10.1007/978-1-4684-5952-4_23. Adv Exp Med Biol. 1991. PMID: 1663311 Review. No abstract available.
-
Pharmacology and function of melatonin receptors.FASEB J. 1988 Sep;2(12):2765-73. doi: 10.1096/fasebj.2.12.2842214. FASEB J. 1988. PMID: 2842214 Review.
-
Immunohistological localization of melatonin in the pineal gland and retina of the rat.J Pineal Res. 1991 Apr;10(3):159-64. doi: 10.1111/j.1600-079x.1991.tb00834.x. J Pineal Res. 1991. PMID: 1652637
-
[Retinal and pineal melatonin--from a circadian signal to therapeutic use].Med Arh. 2004;58(1):61-4. Med Arh. 2004. PMID: 15017910 Review. Bosnian.
Cited by
-
Role of the melatonin system in the control of sleep: therapeutic implications.CNS Drugs. 2007;21(12):995-1018. doi: 10.2165/00023210-200721120-00004. CNS Drugs. 2007. PMID: 18020480 Review.
-
Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration.Mol Neurodegener. 2024 Apr 19;19(1):36. doi: 10.1186/s13024-024-00728-6. Mol Neurodegener. 2024. PMID: 38641847 Free PMC article. Review.
-
Exposure to 2500 lux increases serum melatonin in Venezuelan equine encephalomyelitis.Neurochem Res. 1999 Jun;24(6):775-8. doi: 10.1023/a:1020735730869. Neurochem Res. 1999. PMID: 10447461
-
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.Pharmacol Rev. 2010 Sep;62(3):343-80. doi: 10.1124/pr.110.002832. Epub 2010 Jul 6. Pharmacol Rev. 2010. PMID: 20605968 Free PMC article.
-
The relevance of melatonin to sports medicine and science.Sports Med. 2003;33(11):809-31. doi: 10.2165/00007256-200333110-00003. Sports Med. 2003. PMID: 12959621 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases